Johnson & Johnson is contributing $1 million to support the development of curricula and modernization of training and lab ...

The public-private partnership aims to create a sustainable, skilled talent pipeline to support the state’s rapidly expanding ...

The New Jersey Council of County Colleges today launched NJBioFutures, a workforce development coalition aimed at creating a sustainable ...

Nasal Spray Treating Major Depression Receives FDA Approval For Standalone Use The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms ...

Johnson & Johnson is a holding company ... in 1886 and is headquartered in New Brunswick, NJ.

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend stocks. During a time of great excitement about AI-driven capital gains ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Investor model based on the published ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other healthcare stocks. Healthcare stocks are widely considered a cornerstone of a retirement ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other long term low risk stocks. As the DeepSeek craze ignites a sell-off in the tech sector ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best defensive stocks to buy right now. A notable event influencing current market sentiment ...

High-rolling investors have positioned themselves bearish on Johnson & Johnson JNJ, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy. However ...